コンテンツへスキップ
Merck

Parenteral iron dextran therapy.

DICP : the annals of pharmacotherapy (1990-02-01)
V J Kumpf, E G Holland
要旨

Parenteral iron therapy is indicated in patients with iron-deficiency anemia associated with conditions that interfere with the ingestion or absorption of oral iron. Replacement doses of iron required to replenish iron stores are based on body weight and the observed hemoglobin value. Methods of administering iron dextran are reviewed, including intramuscular and intravenous injections of the undiluted drug, intravenous infusion of a diluted preparation, and as an addition to parenteral nutrition solutions. The overall incidence of adverse reactions associated with the parenteral administration of iron is low, but the potential for an anaphylactic reaction requires that an initial test dose be given followed by careful patient observation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
鉄-デキストラン, 95-105 mg/mL (Iron content), solution